• Company
• Korea Pharma has signed a contract to supply Accrufer
• by Aug 27, 2021 05:59am

• Policy
• Clinical trials of Jardiance have been approved
• by Lee, Tak-Sun Aug 26, 2021 05:58am

• Company
• Who will head Novartis Korea after Joshi Venugopal?
• by Eo, Yun-Ho Aug 26, 2021 05:58am

• Policy
• Ppl willing to pay max ₩13.52 mil. for one-shot therap
• by Kim, Jung-Ju Aug 26, 2021 05:58am

• Company
• GSK will supply Fluarix Tetra through Kwang Dong
• by Aug 26, 2021 05:58am

• Policy
• Drugs caught in rebates for 2 years can be replaced by fines
• by Kim, Jung-Ju Aug 26, 2021 05:58am

• Company
• MSD’s Keytruda becomes the 'symbol' of cancer immunotherapy
• by Eo, Yun-Ho Aug 25, 2021 05:57am

• Policy
• Will the voluntary recovery of AZBT be expanded?
• by Lee, Tak-Sun Aug 25, 2021 05:57am

• Policy
• Opdivo's benefit extends for kidney cancer & parietal cancer
• by Lee, Hye-Kyung Aug 25, 2021 05:57am

• Opinion
• [Reporter's view] Controversy over α-GPC
• by Lee, Hye-Kyung Aug 25, 2021 05:57am